Abstract
Introduction/BackgroundA popular dogma is that in epithelial ovarian carcinomas (EOCs) mutations in BRCA1/2 and other homologous recombination (HR)-genes are exclusive to high-grade serous ovarian carcinomas (HGSOC). Nevertheless, the European guidelines...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
